Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κb signaling pathway

Phytotherapy Research

Volumn 29, Issue 4, 2015, Pages 599-606

  Lu, Meili ^a   Tang, Futian ^a   Zhang, Jing ^a   Luan, Aina ^a   Mei, Meng ^a   Xu, Chonghua ^a   Zhang, Suping ^a   Wang, Hongxin ^a   Maslov, Leonid N ^b  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

Author keywords

apoptosis; astragaloside IV; inflammatory response; myocardial ischemia reperfusion; TLR4 NF B signaling pathway

Indexed keywords

ASTRAGALOSIDE IV; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN BAX; PROTEIN BCL 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ASTRAGALOSIDE A; BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; SAPONIN; TLR4 PROTEIN, RAT; TRITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOTIC EFFECT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; GENERAL ASPECTS OF DISEASE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; INFARCT SIZE; MALE; MOLECULAR DYNAMICS; MORPHOLOGY; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NICK END LABELING; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TREATMENT DURATION; ANIMAL; DRUG EFFECTS; HEART MUSCLE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ASTRAGALUS MEMBRANACEUS; RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; DOWN-REGULATION; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRITERPENES;

EID: 84926482662     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5297     Document Type: Article

References (43)

1. Al-Amran F, Shahkolahi M,. 2013. Oxytocin ameliorates the immediate myocardial injury in rat heart transplant through downregulation of neutrophil-dependent myocardial apoptosis. Transplant Proc 45: 2506-2512.
2. Brown M, McGuinness M, Wright T, et al,. 2005. Cardiac-specific blockade of NF-κB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. Am J Physiol Heart Circ Physiol 289: H466-H476.
3. Chen CC, Young JL, Monzon RI, Chen N, Todorovic V, Lau LF,. 2007. Cytotoxicity of TNFα is regulated by integrin-mediated matrix signaling. EMBO J 26: 1257-1267.
4. Chen K, Li G, Geng F, et al,. 2014. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats. Apoptosis 19: 946-957.
5. Cheng MX, Chen ZZ, Cai YL, Liu CA, Tu B,. 2011. Astragaloside IV protects against ischemia reperfusion in a murine model of orthotopic liver transplantation. Transplant Proc 43: 1456-1461.
6. Cong X, Li Y, Lu N, et al,. 2014. Resveratrol attenuates the inflammatory reaction induced by ischemia/reperfusion in the rat heart. Mol Med Rep 9: 2528-2532.
7. Ding HS, Yang J, Chen P, et al,. 2013. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis. Gene 527: 389-393.
8. Fliss H, Gattinger D,. 1996. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79: 949-956.
9. Frangogiannis NG, Smith CW, Entman ML,. 2002. The inflammatory response in myocardial infarction. Circ Res 53: 31-47.
10. Gui D, Huang J, Guo Y, et al,. 2013. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression. Cytokine 61: 970-977.
11. Guo J, Wang SB, Yuan TY, et al,. 2013. Coptisine protects rat heart against myocardial ischemia/reperfusion injury by suppressing myocardial apoptosis and inflammation. Atherosclerosis 231: 384-391.
12. Ha T, Liu L, Kelley J, Kao R, Williams D, Li C,. 2011. Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid Redox Signal 15: 1875-1893
13. Hadi NR, Al-Amran F, Yousif M, Zamil ST,. 2013. Antiapoptotic effect of simvastatin ameliorates myocardial ischemia/reperfusion injury. ISRN Pharmacology 2013: 815094
14. Hamacher-Brady A, Brady NR, Gottlieb RA,. 2006. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury. Cardiovasc Drugs Ther 20: 445-462.
15. Han XH, Liu P, Zhang YY, Zhang N, Chen FR, Cai JF,. 2011. Astragaloside IV regulates expression of ATP-sensitive potassium channel subunits after ischemia-reperfusion in rat ventricular cardiomyocytes. J Tradit Chin Med 31: 321-326
16. Huang X, Tang L, Wang F, Song G,. 2014. Astragaloside IV attenuates allergic inflammation by regulation Th1/Th2 cytokine and enhancement CD4(+)CD25(+)Foxp3 T cells in ovalbumin-induced asthma. Immunobiology 219: 565-571
17. Kim YS, Kim JS, Kwon JS, et al,. 2010. BAY 11-7082, a nuclear factor-κB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model. Int Heart J 51: 348-353.
18. Kim MH, Kim SH, Yang WM,. 2014. Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling. PLoS One 9: e92984.
19. Li Y, Si R, Feng Y, et al,. 2011. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem 286: 31,308-31,319.
20. Li M, Qu YZ, Zhao ZW, et al,. 2012. Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem Int 60: 458-465.
21. Li M, Ma RN, Li LH, Qu YZ, Gao GD,. 2013. Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4. Eur J Pharmacol 715: 189-195.
22. Liou YM, Hsieh SR, Wu TJ, Chen JY,. 2010. Green tea extract given before regional myocardial ischemia-reperfusion in rats improves myocardial contractility by attenuating calcium overload. Pflugers Arch 460: 1003-1014.
23. Lu M, Wang H, Wang J, et al,. 2014. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway. Planta Med 80: 63-69.
24. Onai Y, Suzuki J, Kakuta T, et al,. 2004. Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res 63: 51-59.
25. Oyama J, Blais C, Jr., Liu X, et al,. 2004. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109: 784-789.
26. Pye J, Ardeshirpour F, McCain A, et al,. 2003. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol 284: H919-H926.
27. Quan W, Wei G, Zhou D, et al,. 2013. Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats via regulating the inflammation response. Pharm Biol 51: 1355-1362.
28. Rios JL, Waterman PG,. 1998. A review of the pharmacology and toxicology of Astragalus. Phytother Res 11: 411-418.
29. Shen HM, Pervaiz S,. 2006. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20: 1589-1598.
30. Stanley WC,. 2004. Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies. J Cardiovasc Pharmacol Ther 9: S31-S45.
31. Sun L, Li W, Li W, Xiong L, Li G, Ma R,. 2014. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NFκB pathway under high glucose conditions. Int J Mol Med 34: 167-176.
32. Tan S, Wang G, Guo Y, Gui D, Wang N,. 2013. Preventive effects of a natural anti-inflammatory agent, astragaloside IV, on ischemic acute kidney injury in rats. Evid Based Complement Alternat Med 2013: 284025.
33. Tu L, Pan CS, Wei XH, Yan L, Liu YY, Fan JY,. 2013. Astragaloside IV protects heart from ischemia and reperfusion injury via energy regulation mechanisms. Microcirculation 20: 736-747
34. Wang S, Li J, Huang H, et al,. 2009. Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali. Biol Pharm Bull 32: 132-135.
35. Wei G, Guan Y, Yin Y, Duan J, Zhou D,. 2013. Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro. Inflammation 36: 592-602.
36. Wu X, Cao Y, Nie J, Liu H, Lu S, Hu X, Zhu J,. 2013. Genetic and pharmacological inhibition of Rheb1-mTORC1 signaling exerts cardioprotection against adverse cardiac remodeling in mice. Am J Pathol 182: 2005-2014.
37. Xu XL, Chen XJ, Ji H, et al,. 2008. Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase. Pharmacology 81: 325-332.
38. Yang J, Zhang XD, Yang J, et al,. 2011. The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4. Mol Biol Rep 38: 3037-3044.
39. Yang J, Wang HX, Zhang YJ, et al,. 2013a. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-small ka, CyrillicB signaling pathway in isoproterenol-induced myocardial hypertrophy. J Ethnopharmacol 150: 1062-1070.
40. Yang Y, Duan W, Lin Y, et al,. 2013b. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med 65: 667-679.
41. Zhang WD, Chen H, Zhang C, Liu RH, Li HL, Chen HZ,. 2006. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med 72: 4-8.
42. Zhang XQ, Tang R, Li L, et al,. 2013. Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling. Am J Physiol Heart Circ Physiol 305 (7): H1089-H1097.
43. Zhao M, Zhao J, He G, Sun X, Huang X, Hao L,. 2013. Effects of astragaloside IV on action potentials and ionic currents in guinea-pig ventricular myocytes. Biol Pharm Bull 36: 515-521.